Objective: To explore the association between striatal dopaminergic deficits and cognitive impairment within a large cohort of early, drug-naive Parkinson’s disease patients and to test the hypothesis that executive dysfunction in Parkinson’s disease is caused by striatal dopaminergic depletion. Background: Cognitive impairment in Parkinson’s disease is common and influences patients’ everyday functioning, but the mechanisms of early cognitive decline are not known. Understanding of these mechanisms is important for the development of methods preventing cognitive decline in Parkinson’s disease. Previous studies suggest that the dopaminergic system influences cognition in PD. Methods: Neuropsychological and cerebral dopamine transporter SPEC...
Aim: The aim of this study was to identify mild cognitive deficits in Parkinson's disease (PD) prior...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underly...
Objectives: Mild cognitive impairment (MCI) is a common feature in Parkinson's disease (PD). We perf...
INTRODUCTION: To investigate the relationship between the sub-regional pattern of striatal dopamine ...
BACKGROUND: Parkinson's disease (PD) affects the integrity of the dopamine and serotonin system, and...
Twenty non-demented patients with idiopathic Parkinson's disease (PD) underwent single photon emissi...
Twenty non-demented patients with idiopathic Parkinson's disease (PD) underwent single photon emissi...
Parkinson's disease is a devastating neurodegenerative disorder with an immense impact on daily life...
Introduction: This study investigated the relationship between white matter hyperintensities (WMHs),...
BackgroundLittle is known about the impact of the dopamine system on development of cognitive impair...
Parkinson’s disease (PD) is next to Alzheimer’s disease (AD) the second most common neurodegenerativ...
Parkinson's disease (PD) patients show cognitive deficits that are relevant in terms of prognosis an...
Parkinson's disease is a devastating neurodegenerative disorder with an immense impact on daily life...
Subtle cognitive impairment can be detected in early Parkinson's disease (PD). In a consecutive seri...
Aim: The aim of this study was to identify mild cognitive deficits in Parkinson's disease (PD) prior...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underly...
Objectives: Mild cognitive impairment (MCI) is a common feature in Parkinson's disease (PD). We perf...
INTRODUCTION: To investigate the relationship between the sub-regional pattern of striatal dopamine ...
BACKGROUND: Parkinson's disease (PD) affects the integrity of the dopamine and serotonin system, and...
Twenty non-demented patients with idiopathic Parkinson's disease (PD) underwent single photon emissi...
Twenty non-demented patients with idiopathic Parkinson's disease (PD) underwent single photon emissi...
Parkinson's disease is a devastating neurodegenerative disorder with an immense impact on daily life...
Introduction: This study investigated the relationship between white matter hyperintensities (WMHs),...
BackgroundLittle is known about the impact of the dopamine system on development of cognitive impair...
Parkinson’s disease (PD) is next to Alzheimer’s disease (AD) the second most common neurodegenerativ...
Parkinson's disease (PD) patients show cognitive deficits that are relevant in terms of prognosis an...
Parkinson's disease is a devastating neurodegenerative disorder with an immense impact on daily life...
Subtle cognitive impairment can be detected in early Parkinson's disease (PD). In a consecutive seri...
Aim: The aim of this study was to identify mild cognitive deficits in Parkinson's disease (PD) prior...
Objective: Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable t...
Introduction: Mild cognitive impairment (MCI) is common in Parkinson’s disease (PD), but the underly...